Search Results - "Kehoe, Patrick G"

Refine Results
  1. 1

    Cognitive impact of COVID-19: looking beyond the short term by Miners, Scott, Kehoe, Patrick G, Love, Seth

    Published in Alzheimer's research & therapy (30-12-2020)
    “…COVID-19 is primarily a respiratory disease but up to two thirds of hospitalised patients show evidence of central nervous system (CNS) damage, predominantly…”
    Get full text
    Journal Article
  2. 2

    Repurposing antihypertensive drugs for the prevention of Alzheimer’s disease: a Mendelian randomization study by Walker, Venexia M, Kehoe, Patrick G, Martin, Richard M, Davies, Neil M

    Published in International journal of epidemiology (01-08-2020)
    “…Abstract Background Evidence concerning the potential repurposing of antihypertensives for Alzheimer’s disease prevention is inconclusive. We used Mendelian…”
    Get full text
    Journal Article
  3. 3

    ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease by Evans, Charles E., Miners, James S., Piva, Giulia, Willis, Christine L., Heard, David M., Kidd, Emma J., Good, Mark A., Kehoe, Patrick G.

    Published in Acta neuropathologica (01-03-2020)
    “…Mid-life hypertension and cerebrovascular dysfunction are associated with increased risk of later life dementia, including Alzheimer’s disease (AD). The…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Small RNA modifications in Alzheimer's disease by Zhang, Xudong, Trebak, Fatima, Souza, Lucas A.C., Shi, Junchao, Zhou, Tong, Kehoe, Patrick G., Chen, Qi, Feng Earley, Yumei

    Published in Neurobiology of disease (01-11-2020)
    “…Background While significant advances have been made in uncovering the aetiology of Alzheimer's disease and related dementias at the genetic level, molecular…”
    Get full text
    Journal Article
  6. 6

    Is inhibition of the renin–angiotensin system a new treatment option for Alzheimer's disease? by Kehoe, Patrick G, Dr, Wilcock, Gordon K, FRCP

    Published in Lancet neurology (01-04-2007)
    “…Summary Findings from longitudinal and cross-sectional studies suggest an association between high blood pressure and dementia, and in turn the use of…”
    Get full text
    Journal Article
  7. 7

    Alzheimer's disease–like pathology has transient effects on the brain and blood metabolome by Pan, Xiaobei, Nasaruddin, Muhammad Bin, Elliott, Christopher T, McGuinness, Bernadette, Passmore, Anthony P, Kehoe, Patrick G, Hölscher, Christian, McClean, Paula L, Graham, Stewart F, Green, Brian D

    Published in Neurobiology of aging (01-02-2016)
    “…Abstract The pathogenesis of Alzheimer's disease (AD) is complex involving multiple contributing factors. The extent to which AD pathology affects the…”
    Get full text
    Journal Article
  8. 8

    Pathophysiology of white matter perfusion in Alzheimer’s disease and vascular dementia by Barker, Rachel, Ashby, Emma L., Wellington, Dannielle, Barrow, Vivienne M., Palmer, Jennifer C., Kehoe, Patrick G., Esiri, Margaret M., Love, Seth

    Published in Brain (London, England : 1878) (01-05-2014)
    “…The pathophysiology of white matter hypoperfusion is poorly understood. Barker et al. quantify ante-mortem hypoperfusion by measuring myelin proteins…”
    Get full text
    Journal Article
  9. 9

    Lipid Profiling of Alzheimer's Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism by Akyol, Sumeyya, Ugur, Zafer, Yilmaz, Ali, Ustun, Ilyas, Gorti, Santosh Kapil Kumar, Oh, Kyungjoon, McGuinness, Bernadette, Passmore, Peter, Kehoe, Patrick G, Maddens, Michael E, Green, Brian D, Graham, Stewart F

    Published in Cells (Basel, Switzerland) (29-09-2021)
    “…Alzheimer's disease (AD) is reported to be closely linked with abnormal lipid metabolism. To gain a more comprehensive understanding of what causes AD and its…”
    Get full text
    Journal Article
  10. 10

    Metabolomic Profiling of Bile Acids in Clinical and Experimental Samples of Alzheimer's Disease by Pan, Xiaobei, Elliott, Christopher T, McGuinness, Bernadette, Passmore, Peter, Kehoe, Patrick G, Hölscher, Christian, McClean, Paula L, Graham, Stewart F, Green, Brian D

    Published in Metabolites (17-06-2017)
    “…Certain endogenous bile acids have been proposed as potential therapies for ameliorating Alzheimer's disease (AD) but their role, if any, in the…”
    Get full text
    Journal Article
  11. 11

    CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer's disease by Weir, Heather J M, Murray, Tracey K, Kehoe, Patrick G, Love, Seth, Verdin, Eric M, O'Neill, Michael J, Lane, Jon D, Balthasar, Nina

    Published in PloS one (06-11-2012)
    “…Progressive mitochondrial dysfunction contributes to neuronal degeneration in age-mediated disease. An essential regulator of mitochondrial function is the…”
    Get full text
    Journal Article
  12. 12

    BIN1 is decreased in sporadic but not familial Alzheimer's disease or in aging by Glennon, Elizabeth B C, Whitehouse, Isobel J, Miners, J Scott, Kehoe, Patrick G, Love, Seth, Kellett, Katherine A B, Hooper, Nigel M

    Published in PloS one (21-10-2013)
    “…Bridging integrator 1 (BIN1) has been implicated in sporadic Alzheimer's disease (AD) by a number of genome wide association studies (GWAS) in a variety of…”
    Get full text
    Journal Article
  13. 13

    Distribution and Expression of Picalm in Alzheimer Disease by Baig, Shabnam, Joseph, Sally A, Tayler, Hannah, Abraham, Richard, Owen, Michael J, Williams, Julie, Kehoe, Patrick G, Love, Seth

    “…PICALM, the gene encoding phosphatidylinositol-binding clathrin assembly (picalm) protein, was recently shown to be associated with risk of Alzheimer disease…”
    Get full text
    Journal Article
  14. 14

    Large Meta-Analysis Establishes the ACE Insertion-Deletion Polymorphism as a Marker of Alzheimer's Disease by Lehmann, Donald J., Cortina-Borja, Mario, Warden, Donald R., Smith, A. David, Sleegers, Kristel, Prince, Jonathan A., van Duijn, Cornelia M., Kehoe, Patrick G.

    Published in American journal of epidemiology (15-08-2005)
    “…Apolipoprotein E ε4 (APOE*4) is the only fully established susceptibility allele for Alzheimer's disease. One of the most studied candidates is the insertion…”
    Get full text
    Journal Article
  15. 15

    What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink by Walker, Venexia M, Davies, Neil M, Kehoe, Patrick G, Martin, Richard M

    Published in Alzheimer's research & therapy (29-05-2018)
    “…Drugs for dementia have been available in England since 1997. Since their launch, there have been several changes to national guidelines and initiatives that…”
    Get full text
    Journal Article
  16. 16

    LRP1 expression in cerebral cortex, choroid plexus and meningeal blood vessels: Relationship to cerebral amyloid angiopathy and APOE status by Ruzali, Wan Adriyani W., Kehoe, Patrick G., Love, Seth

    Published in Neuroscience letters (13-09-2012)
    “…► LRP1 mRNA is elevated in meningeal vessels in association with APOE ɛ4. ► LRP1 mRNA is elevated in choroid plexus and meningeal vessels with AD. ► APOE ɛ2 is…”
    Get full text
    Journal Article
  17. 17

    Prion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid-β levels and Braak stage by Whitehouse, Isobel J, Miners, J Scott, Glennon, Elizabeth B C, Kehoe, Patrick G, Love, Seth, Kellett, Katherine A B, Hooper, Nigel M

    Published in PloS one (05-04-2013)
    “…The cellular prion protein (PrP(C)) has been implicated in the development of Alzheimer's disease (AD). PrP(C) decreases amyloid-β (Aβ) production, which is…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Divergence in the activity of the N- and C- catalytic domains of ACE1 - implications for the role of the renin-angiotensin system in Alzheimer's disease by Al Mulhim, Noura S, Kehoe, Patrick G, Miners, J Scott

    Published in Acta neuropathologica communications (24-04-2019)
    “…Keywords: Angiotensin-II converting enzyme-1 (ACE1), Alzheimer's disease, Renin-angiotensin system, Anti-hypertensives…”
    Get full text
    Journal Article
  20. 20

    Evidence That Parietal Lobe Fatty Acids May Be More Profoundly Affected in Moderate Alzheimer's Disease (AD) Pathology Than in Severe AD Pathology by Nasaruddin, Muhammad L, Pan, Xiaobei, McGuinness, Bernadette, Passmore, Peter, Kehoe, Patrick G, Hölscher, Christian, Graham, Stewart F, Green, Brian D

    Published in Metabolites (26-10-2018)
    “…Brain is a lipid-rich tissue, and fatty acids (FAs) play a crucial role in brain function, including neuronal cell growth and development. This study used…”
    Get full text
    Journal Article